Notizia - Recent Pharma, Healthcare and Biotech Happenings

MedTech News for BioGX, Stryker, Boston Scientific, Agilent, DexCom

Notizia - Recent Pharma, Healthcare and Biotech Happenings

BioGX’s ‘pixl’ Portable qPCR Platform; Stryker’s Citrefix Suture Anchor System; Boston Scientific to Acquire Majority Stake of Acotec Scientific; FDA Approved the Dexcom G7 CGM System; Agilent’s NSCLC Liquid Biopsy Companion Diagnostic Test Approval; ClearPoint Neuro’s Prism™ Neuro Laser Therapy

Explore More...
latest-medtech-news-and-updates-from-abbott-bd-procyrion-tricvalve

Latest Medtech Commercial, Regulatory and Clinical Updates For – Abbott, BD, CooperVision, Procyrion, TricValve, and others

pharma-news-updates-for-amgen-verrica-nexturn-rosvivo-fennec

Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec’s Faith in its Chemotherapy-Induced Hearing Loss Drug; Nexturn Bio’s Acquisition of RosVivo

Latest-pharma-biotech-news-updates-for-pieris-genentech-xilio-merck-bms-xencor

Pieris-Genentech deal; Xilio inks deal with Merck; BMS taps Xencor’s tech; GenSight’s gene therapy reports partial recovery

Another Failed NASH Drug; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; TLX66 in AL Amyloidosis

TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Another Failed NASH Drug

medtech-news-updates-approvals

MedTech Industry: Commercial, Regulatory and Clinical Updates

recent-pharma-biotech-news-updates-for-sanofi-gsk-apellis-innocare-landos

InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio, Landos Collab

recent-pharma-happenings-for-eli-lilly-mina-appia-bio-nuvalent

Lilly ink deal with MiNA; Appia Bio aims for CAR-T with $52M raise; Nuvalent raises $135M; Orchard gene therapy benefits kids

Pfizer/BioNTech COVID-19 Vaccine; Biogen/Capsigen Deal

Abingworth & Alebund’s Finacial Closing; Pfizer/BioNTech COVID-19 Vaccine Expanded Use; Biogen and Capsigen Deal

recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

recent-pharma-news-update

MedTech Industry Roars Back as FDA Approvals Soar

recent-pharma-biotech-news-updates-happenings-for-abbott-biogen-eli-lilly-arch-oncology

Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis program; Biogen offer access to experimental ALS med

recent-pharma-biotech-lifescience-healthcare-news-updates-for-vertex-virta-kalvista-ovid-crispr-therapeutics

Vertex leads in CRISPR Therapeutics deal; Update for Phase 2 clinical trial of KVD824; Ovid dumps lead program; Virta Health pulls in $133M

recent-biotech-pharma-lifescience-industry-news-updates-for-adagio-lyndra-bms-anixa

Adagio Raises $336 M; Lyndra’s Schizo Trial; BMS Opdivo for Gastric Cancer; Anixa Ovarian Cancer CAR-T Therapy

recent-pharma-happenings-for-recursion-repertoire-cequr-eli-lilly

Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recursion sets terms for $306M IPO

recent-pharma-news-and-updates-for-astrazeneca-sanofi-taysha

Taysha Acquires Rare Disease Gene Therapy For $5.5 M; AZ’s Farxiga Fails In COVID-19 Study; Sanofi To Strengthen Its Vaccines Manufacturing Capacities

recent-pharma-news-updates-for-artios-scholar-rock-novavax-volastra

Artios collaborates with Novartis; Scholar Rock eyes Phase III trial; Novavax starts crossover arms in Covid-19 trials; Volastra nabs $44M

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader